Company Filing History:
1 out of 447 
1 out of 8,405 
1 out of 2,982 
Years Active: 2023
Title: The Innovative Contributions of Daniel Neafsey
Introduction
Daniel Neafsey is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of diagnostics. He holds a patent that showcases his innovative approach to malaria detection using advanced CRISPR technology. His work has the potential to revolutionize how diseases are diagnosed and treated.
Latest Patents
Neafsey's most notable patent is titled "CRISPR effector system based diagnostics for malaria detection." This invention utilizes RNA targeting effectors to create a robust CRISPR-based diagnostic tool with attomolar sensitivity. The technology can detect both DNA and RNA with comparable sensitivity levels and can differentiate between targets and non-targets based on single base pair differences. Additionally, the diagnostic system can be prepared in a freeze-dried format, making it convenient for distribution and point-of-care applications. This innovation is particularly useful in various health scenarios, including viral detection, bacterial strain typing, sensitive genotyping, and the detection of disease-associated cell-free DNA.
Career Highlights
Throughout his career, Daniel Neafsey has worked with esteemed organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Neafsey has collaborated with notable individuals in the scientific community, including Omar O Abudayyeh and James Joseph Collins. These collaborations have further enhanced his research and development efforts in the field of diagnostics.
Conclusion
Daniel Neafsey's innovative work in CRISPR-based diagnostics exemplifies the potential of modern technology in improving health outcomes. His contributions are paving the way for more effective disease detection methods, particularly in malaria and other health-related scenarios.